Hallmarks of Cancer and Pharmaceutical Targets Flashcards
Evading growth suppressors
CDK inhibitors
Avoiding immune destruction
Immune activating anti-CTLA4 mAb
Enabling replicative immortality
Telomerase inhibitors
Tumor-promoting inflammation
Selective anti-inflammatory drugs
Activating invasion and metastasis
Inhibitors of HGF/c-Met
Inducing angiogenesis
Inhibitors of VEGF signaling
Genome instability and mutation
PARP inhibitors
Resisting cell death
Proapoptotic BH3 mimetics
Deregulating cellular energetics
Aerobic glycolysis inhibitors
MDM2 inhibitors
Indirectly brings back p53
Ipilimumab
CTLA-4 inhibitor
Pembrolizumab
Binds PD-1
Imetelstat
Telomerase inhibitor
Bevacuzimab
VEGF inhibition
DNA-Damaging Drugs
Cell cycle dependent; alkylating agents, topoisomerase inhibitors, antibiotics